跳至主要内容
临床试验/CTRI/2025/07/091913
CTRI/2025/07/091913尚未招募2 期

Clinical Validation of Fasd (Venesection) in the management of Khafqan (Palpitations): A Randomized open label study with standard control

Central Council for Research in Unani Medicine CCRUM New Delhi1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年8月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
ECG

研究概览

简要总结

Khafqan or palpitation is haracterized by an awareness of the beating of the heart.Patients commonly describe pounding or fluttering heart beats or reports a sensation that the heart is stopping or skipping beats.In unani system of medicine heart is one of the three fundamental organs of the body.Heart is considered as the cheif of vital organs and palpitation is described as critical for heart ailments.Avicenna in his renowed book Cnon of medicine has mentioned palpitation as follows: Palpitation is an irregular mvement of heart.This may be caused by heart utself, pericardium, neighbouring or associated organs.It ocurs due to humoral deragement, simple morbid temperament, inflammatory conditions, dissolution, extrinsic factors or hypersentivity.

Moderm management first line therapy for symptomatic palpitations is beta blocker or calcium channel blocker.Patients who are refractory to medical therapy or who develop left ventricular dysfunction should undergo catheter ablation of premature ventricular contractions.However there are number of drugs and regimens in unani system of medicine for khafqan which are safe and effective.Unani management includes evacuation if is caused by predominance of humous.Evacuation id done through emesis and purgation if it is caused by gastric involvement.In this respect A study entitled Clinical validation of Fasd (Venesection) in the management of Khafqan (Palpitations): A randamized open labelled study with standard control study has been designed.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Clinically diagnosed patients of Khafqan (Palpitations) Patients in age group of 18 to 65 irrespective of gender Patients who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily.

排除标准

  • Known cases of Arrhythmias and any bleeding disorders (Thalassemia Hemophilia Menorrhagia or any blood-dyscrasias) Moderate to Severe Anemic patients Viral Infections like STDs (AIDS Hepatitis B & C) Known case of uncontrolled Diabetes Mellitus & HTN Patients below 18 years and above 65 years History of substance abuse: Caffeine Alcohol Drug intoxication Patient who fails to followup Patient who fails to give writtenconsent Known cases of Hyperthyroidism Cardiovascular diseass Renal disease and Liver disease Pregnant and lactating mother.

结局指标

主要结局

ECG

时间窗: 60days

VAS (Visual Analogue Scale)

时间窗: 60days

次要结局

  • tachycardia(Hypertension)

研究者

发起方
Central Council for Research in Unani Medicine CCRUM New Delhi
申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr Mohammed Sheeraz Mushtaque Ahmed

Regional Research Institute of Unani Medicine,Habbak Srinagar

研究点 (1)

Loading locations...

相似试验

Effect of Venesection in the management of... | 临床试验